Selected research
Industry Growth & Trends
Global Biologics Process Development Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Biologics Process Development Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Biologics Process Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Biologics Process Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biologics Process Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Biologics Process Development Service market include AGC Biologics, Bora Biologics, Canton Biologics, Catalent Biologics, Evotec, HIPRA, Kemwell Pharma, Lonza and Mabion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Biologics Process Development Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Biologics Process Development Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biologics Process Development Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biologics Process Development Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Biologics Process Development Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Biologics Process Development Service Market by Company
AGC Biologics
Bora Biologics
Canton Biologics
Catalent Biologics
Evotec
HIPRA
Kemwell Pharma
Lonza
Mabion
NorthX Biologics
Pace Analytical
Rodon Biologics
Samsung Biologics
Sartorius
Thermo Fisher Scientific
WuXi Biologics
Biologics Process Development Service Segment by Type
R&D Scale (1-3L)
Pilot and Scale-Up (50-500L)
Clinical and Commercial Production Scale (1000L and Above)
Biologics Process Development Service Segment by Application
Contract Development and Manufacturing Organization (CDMO)
Professional Technical Service Provider
Large Pharmaceutical Company
Research Institute
Biologics Process Development Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologics Process Development Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biologics Process Development Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologics Process Development Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Biologics Process Development Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- R&D Scale (1-3L)
- Pilot and Scale-Up (50-500L)
- Clinical and Commercial Production Scale (1000L and Above)
Applications
- Contract Development and Manufacturing Organization (CDMO)
- Professional Technical Service Provider
- Large Pharmaceutical Company
- Research Institute
Companies covered
- AGC Biologics
- Bora Biologics
- Canton Biologics
- Catalent Biologics
- Evotec
- HIPRA
- Kemwell Pharma
- Lonza
- Mabion
- NorthX Biologics
- Pace Analytical
- Rodon Biologics
- Samsung Biologics
- Sartorius
- Thermo Fisher Scientific
- WuXi Biologics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Biologics Process Development Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Biologics Process Development Service Market Size by Region (2021-2032)
- 1.4.1 Global Biologics Process Development Service Market Size by Region (2021-2026)
- 1.4.2 Global Biologics Process Development Service Market Size by Region (2027-2032)
- 1.5 Key Regions Biologics Process Development Service Market Size (2021-2032)
- 1.5.1 North America Biologics Process Development Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Biologics Process Development Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Biologics Process Development Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Biologics Process Development Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Biologics Process Development Service Market Size Growth Rate (2021-2032)
2 Biologics Process Development Service Market by Type
- 2.1 Type Introduction
- 2.1.1 R&D Scale (1-3L)
- 2.1.2 Pilot and Scale-Up (50-500L)
- 2.1.3 Clinical and Commercial Production Scale (1000L and Above)
- 2.2 Global Biologics Process Development Service Market Size by Type
- 2.2.1 Global Biologics Process Development Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Biologics Process Development Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Biologics Process Development Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Biologics Process Development Service Market Size by Regions
- 2.3.1 North America Biologics Process Development Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Biologics Process Development Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Biologics Process Development Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Biologics Process Development Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Biologics Process Development Service Market Size Breakdown by Type (2021-2026)
3 Biologics Process Development Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Contract Development and Manufacturing Organization (CDMO)
- 3.1.2 Professional Technical Service Provider
- 3.1.3 Large Pharmaceutical Company
- 3.1.4 Research Institute
- 3.2 Global Biologics Process Development Service Market Size by Application
- 3.2.1 Global Biologics Process Development Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Biologics Process Development Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Biologics Process Development Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Biologics Process Development Service Market Size by Regions
- 3.3.1 North America Biologics Process Development Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Biologics Process Development Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Biologics Process Development Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Biologics Process Development Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Biologics Process Development Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Biologics Process Development Service Industry Trends
- 4.2 Biologics Process Development Service Industry Drivers
- 4.3 Biologics Process Development Service Industry Opportunities and Challenges
- 4.4 Biologics Process Development Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Biologics Process Development Service Revenue (2021-2026)
- 5.2 Global Biologics Process Development Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Biologics Process Development Service Key Company Headquarters & Area Served
- 5.4 Global Biologics Process Development Service Company, Product Type & Application
- 5.5 Global Biologics Process Development Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Biologics Process Development Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Biologics Process Development Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Biologics Process Development Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 AGC Biologics
- 6.1.1 AGC Biologics Company Information
- 6.1.2 AGC Biologics Business Overview
- 6.1.3 AGC Biologics Biologics Process Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 AGC Biologics Biologics Process Development Service Product Portfolio
- 6.1.5 AGC Biologics Recent Developments
- 6.2 Bora Biologics
- 6.2.1 Bora Biologics Company Information
- 6.2.2 Bora Biologics Business Overview
- 6.2.3 Bora Biologics Biologics Process Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Bora Biologics Biologics Process Development Service Product Portfolio
- 6.2.5 Bora Biologics Recent Developments
- 6.3 Canton Biologics
- 6.3.1 Canton Biologics Company Information
- 6.3.2 Canton Biologics Business Overview
- 6.3.3 Canton Biologics Biologics Process Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Canton Biologics Biologics Process Development Service Product Portfolio
- 6.3.5 Canton Biologics Recent Developments
- 6.4 Catalent Biologics
- 6.4.1 Catalent Biologics Company Information
- 6.4.2 Catalent Biologics Business Overview
- 6.4.3 Catalent Biologics Biologics Process Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Catalent Biologics Biologics Process Development Service Product Portfolio
- 6.4.5 Catalent Biologics Recent Developments
- 6.5 Evotec
- 6.5.1 Evotec Company Information
- 6.5.2 Evotec Business Overview
- 6.5.3 Evotec Biologics Process Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Evotec Biologics Process Development Service Product Portfolio
- 6.5.5 Evotec Recent Developments
- 6.6 HIPRA
- 6.6.1 HIPRA Company Information
- 6.6.2 HIPRA Business Overview
- 6.6.3 HIPRA Biologics Process Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 HIPRA Biologics Process Development Service Product Portfolio
- 6.6.5 HIPRA Recent Developments
- 6.7 Kemwell Pharma
- 6.7.1 Kemwell Pharma Company Information
- 6.7.2 Kemwell Pharma Business Overview
- 6.7.3 Kemwell Pharma Biologics Process Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Kemwell Pharma Biologics Process Development Service Product Portfolio
- 6.7.5 Kemwell Pharma Recent Developments
- 6.8 Lonza
- 6.8.1 Lonza Company Information
- 6.8.2 Lonza Business Overview
- 6.8.3 Lonza Biologics Process Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Lonza Biologics Process Development Service Product Portfolio
- 6.8.5 Lonza Recent Developments
- 6.9 Mabion
- 6.9.1 Mabion Company Information
- 6.9.2 Mabion Business Overview
- 6.9.3 Mabion Biologics Process Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Mabion Biologics Process Development Service Product Portfolio
- 6.9.5 Mabion Recent Developments
- 6.10 NorthX Biologics
- 6.10.1 NorthX Biologics Company Information
- 6.10.2 NorthX Biologics Business Overview
- 6.10.3 NorthX Biologics Biologics Process Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 NorthX Biologics Biologics Process Development Service Product Portfolio
- 6.10.5 NorthX Biologics Recent Developments
- 6.11 Pace Analytical
- 6.11.1 Pace Analytical Company Information
- 6.11.2 Pace Analytical Business Overview
- 6.11.3 Pace Analytical Biologics Process Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Pace Analytical Biologics Process Development Service Product Portfolio
- 6.11.5 Pace Analytical Recent Developments
- 6.12 Rodon Biologics
- 6.12.1 Rodon Biologics Company Information
- 6.12.2 Rodon Biologics Business Overview
- 6.12.3 Rodon Biologics Biologics Process Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Rodon Biologics Biologics Process Development Service Product Portfolio
- 6.12.5 Rodon Biologics Recent Developments
- 6.13 Samsung Biologics
- 6.13.1 Samsung Biologics Company Information
- 6.13.2 Samsung Biologics Business Overview
- 6.13.3 Samsung Biologics Biologics Process Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Samsung Biologics Biologics Process Development Service Product Portfolio
- 6.13.5 Samsung Biologics Recent Developments
- 6.14 Sartorius
- 6.14.1 Sartorius Company Information
- 6.14.2 Sartorius Business Overview
- 6.14.3 Sartorius Biologics Process Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Sartorius Biologics Process Development Service Product Portfolio
- 6.14.5 Sartorius Recent Developments
- 6.15 Thermo Fisher Scientific
- 6.15.1 Thermo Fisher Scientific Company Information
- 6.15.2 Thermo Fisher Scientific Business Overview
- 6.15.3 Thermo Fisher Scientific Biologics Process Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Thermo Fisher Scientific Biologics Process Development Service Product Portfolio
- 6.15.5 Thermo Fisher Scientific Recent Developments
- 6.16 WuXi Biologics
- 6.16.1 WuXi Biologics Company Information
- 6.16.2 WuXi Biologics Business Overview
- 6.16.3 WuXi Biologics Biologics Process Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 WuXi Biologics Biologics Process Development Service Product Portfolio
- 6.16.5 WuXi Biologics Recent Developments
7 North America
- 7.1 North America Biologics Process Development Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Biologics Process Development Service Market Size by Country (2021-2026)
- 7.3 North America Biologics Process Development Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Biologics Process Development Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Biologics Process Development Service Market Size by Country (2021-2026)
- 8.3 Europe Biologics Process Development Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Biologics Process Development Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Biologics Process Development Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Biologics Process Development Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Biologics Process Development Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Biologics Process Development Service Market Size by Country (2021-2026)
- 10.3 South America Biologics Process Development Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Biologics Process Development Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Biologics Process Development Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Biologics Process Development Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst